STOCK TITAN

Nephros to Participate in M-Vest LLC and Maxim Group LLC Inaugural Emerging Growth Virtual Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

SOUTH ORANGE, NJ, March 10, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, today announced that Andy Astor, Chief Executive Officer, has been invited to present at the Inaugural Emerging Growth Virtual Conference, presented by M-Vest LLC and Maxim Group LLC. The conference will take place on March 17th and 18th from 9:00 am-5:00 pm EST, featuring roundtable discussions with C-suite executives moderated by Maxim Research Analysts, fireside chats with live Q&A, and presentations from hundreds of issuers both domestically and internationally.

During this virtual conference, Nephros will provide an overview of how they are advancing water safety through pathogen detection and water purification.  The conference will feature roundtable discussions, issuer presentations, fireside chats, and live Q&A with company CEOs moderated by Maxim Research Analysts.

To learn more about attending, sign up for M-Vest HERE.

About Nephros

Nephros is a leading water technology company in medical and commercial water purification and pathogen detection, headquartered in the USA. Our diverse team of passionate employees are dedicated to advancing point-of-use water safety through education, product solutions, and emergency outbreak response management.

For more information about Nephros, please visit www.nephros.com.

Investor Relations Contact:

Kirin Smith, President

PCG Advisory, Inc.

(646) 823-8656

ksmith@pcgadvisory.com

www.pcgadvisory.com


Company Contact:

Andy Astor, President and CEO

Nephros, Inc.

(201) 345-0824

andy@nephros.com

www.nephros.com


Nephros, Inc.

NASDAQ:NEPH

NEPH Rankings

NEPH Latest News

NEPH Stock Data

23.41M
5.62M
11.96%
40.29%
0.02%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States of America
SOUTH ORANGE

About NEPH

nephros is a commercial stage medical device company that develops and sells high performance liquid purification filters. nephros filters capture contaminants as small as 5 nanometers in size; they minimize exposure to a wide variety of bacteria, viruses, fungi, parasites, and endotoxins. nephros filters use a proprietary hollow fiber technology; the hollow fiber design enables the filters to optimize the three elements critical to filter performance: • filtration – as low as 5 nanometers • flow rate – minimal disruption • filter life – up to 12 months nephros was founded in 1997, by healthcare professionals affiliated with columbia university medical center, initially to address the needs of chronic renal failure patients. the company has developed an alternative to current hemodialysis therapy known as mid-dilution hemodiafiltration (mid-hdf). nephros’ proprietary blood purification technologies enable mid-hdf to be offered to chronic renal failure patients. nephros mid-dilution fil